INM

InMed Pharmaceuticals Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Total Trades

7

Buys

6

Sells

1

Largest Trade

$1K–$15K

Insiders

5

Institutional Funds

5

Inst. Value

$1K–$15K

Activist Filings

1

Insider Trades

InsiderTitleTypeValueSharesPriceDate
MANCINI ALEXANDRA DIANE JANETInsiderSELL<$1K240$0.18Aug 2, 2024
HULL ANDREWDirectorBUY$1K–$15K38K$0.39Feb 22, 2024
ADAMS ERIC APresident & CEOBUY$1K–$15K42K$0.36Feb 21, 2024
ADAMS ERIC APresident & CEOBUY$1K–$15K14K$0.89Apr 18, 2022
ADAMS ERIC APresident & CEOBUY$1K–$15K9K$0.85Apr 14, 2022
COLWILL BRUCECFOBUY$1K–$15K5K$1.09Jan 24, 2022
Johnson Shane AaronSVPBUY$1K–$15K9K$1.26Jan 6, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 5 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

SABBY MANAGEMENT, LLC

SC 13G · Jan 20, 2026

9.9%

280K shares

View on Google Finance →